diagnostics

VedaBio debuts with $40M for CRISPR diagnostics

VedaBio raises $40 million to develop CRISPR-based diagnostics

Anika Sharma

A groundbreaking venture, VedaBio, has emerged from stealth mode with an ambitious vision of advancing CRISPR technology to new heights. ...

Contract research organization, mergers and acquisitions, diagnostics, clinical trial supplies, M&A, Cerba HealthCare, Cirion Biopharma

Cerba HealthCare buys Cirion Biopharma to boost bioanalytical services

Anika Sharma

French clinical trial lab and diagnostics provider Cerba HealthCare has acquired Canadian CRO Cirion Biopharma in a move aimed at ...